cGMP EXPERTS IN ADVANCED THERAPIES AND MULTIMODAL BIOMANUFACTURING

GeneSuites specializes in developing a novel plug-and-manufacture platform that is flexible, scalable, and accelerates speed to market to bring life-saving cures to the people who need them most.

Sign Up + Learn More.

Interested in learning more about GeneSuites and our cGMP solutions? We want to hear from you.

arrow&v
PREFERRED LOCATION:

Your form was successfully submitted.

Thank you for your interest in GeneSuites.

FEATURED PROJECT

Catalyst BioCampus Aerial Rendering
LOGO_Catalyst_01.png

Catalyst BioCampus is the first cGMP facility offering High-Performance Shell, allowing companies to fit out their space specific to their modality and process while benefiting from critical schedule and cost advantages compared to the typical cold shell offering.

 

Over 300,000 SF of purpose-built cGMP space at Catalyst BioCampus is currently under construction in Raleigh Durham, NC and is on track to be operational by Q4 2023. GeneSuites is developing Catalyst BioCampus in partnership with affiliates of Apollo Global Management.